Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Danielle Christmas
  • May 26, 2020
  • Blogs

The impact of COVID-19 on rare disease patients in the EU

 The impact of COVID-19 on rare disease patients in the EU

We’re living in challenging times. Everyone is struggling in some way or another as a result of the ongoing lockdowns and current social distancing measures that are in place, aimed at shielding mankind from the ‘invisible enemy’ that is COVID-19. Over the last few months, as we’ve all been muddling through, I have often found myself thinking about those people who are living with a rare disease, and the additional impact that the pandemic must be having on their lives.

read more »

  • Posted by Rachel Howard
  • May 13, 2020
  • Blogs

Pharma vs. The movies: Battle of the blockbusters

Pharma vs. The movies: Battle of the blockbusters

Rachel Howard takes a look at how the pharmaceutical industry is portrayed in Hollywood films and asks the question, is now the time for pharma to take back control of the narrative?

Over the last few weeks living in lockdown, many of us (myself included) have found ourselves working our way through the back catalogues of Netflix, Hulu, Amazon Prime and the like to keep ourselves entertained.  Since Covid-19 first emerged earlier this year, the 2011 drama Contagion has shot back up the charts to become one of the most watched films online. At first I was surprised – isn’t a disaster movie about a pandemic the last thing people want to watch when they’re actually living through one in real life!? But then I thought, perhaps entertainment like this is a way of helping us make sense of the complexity and confusion that is currently surrounding us. Lending us a narrative to anchor ourselves to, by telling us a story that can structure the ongoing uncertainty into something that has a beginning, a middle and an end. Especially since Contagion feels like an eerily prescient depiction of current events - although fortunately we haven’t (yet?) experienced quite the same level of raging anarchy, looting and shooting.

read more »

  • Posted by Misti Paul
  • April 7, 2020
  • Blogs

COVID-19 and Artificial Intelligence

COVID-19 and Artificial Intelligence

Analytics Director Misti Paul takes a look at how organisations worldwide are employing AI to try and combat the virus.

As COVID-19 continues to spread all over the world, threatening to bring healthcare systems to their knees, there are now over 1.2 million cases reported worldwide and sadly over 70,000 deaths. At Research Partnership, we wanted to take a look at how organisations worldwide are employing AI to try and combat the Coronavirus: Baidu’s AI Team Open Sources LinearFold: The AI team at Baidu has released a tool, LinearFold, which reduces 2019-nCoV prediction time from 55 minutes to 27 seconds. This reduction in prediction time is crucial for understanding the virus and accelerate drug discovery. BlueDot Surveillance: A Toronto-based health surveillance company, BlueDot, is working towards making predictions on the spread of COVID-19 by gathering disease data from myriad online sources. Earlier last month they used airline flight information to make predictions about where infectious diseases may appear next, since air travel is a common vector in communicable diseases. AliBaba’s AI system: Alibaba’s Jack Ma claimed that its new AI system can detect coronavirus in CT scans of patients’ chests with 96% accuracy against viral pneumonia cases. In March, Alibaba sent their first consignment of 500,000 testing kits and 1 million masks to the US and consignments of supplies to…

read more »

  • Posted by Anthony Greenwood
  • March 18, 2020
  • Blogs

COVID 19 and behavioural science

COVID 19 and behavioural science

The recent coronavirus outbreak is a clear concern for everyone. What has been interesting to me is how front and centre behavioural science has been in the government’s response to the ongoing crisis. In listening to the Prime Minister in his address to the UK nation on Monday it was noteworthy in his statements how, when he references the role of science in guiding their approach, he explicitly talked as much about behavioural science as he did about the science behind the disease. 

read more »

  • Posted by Rebecca Davies
  • October 15, 2019
  • Blogs

The timely tracking of a global launch

The timely tracking of a global launch

Managing ATUs with staggered launches across multiple markets can be tricky. Research Director Rebecca Davies outlines how we approach the challenge.

A key challenge faced by our clients running global tracking studies is when to track. For a product yet to launch, commercialisation can vary by market by months or years. Typically, data is collected at 3 key stages - a time point prior to launch, a couple of months post launch and then at regular intervals. The issue is - how can ATU projects be managed when a product is due to be commercialised at different time points across markets? 

read more »